Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors

Details for Australian Patent Application No. 2004238515 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Thakkar, Kshitij Chhabilbhai; Berthel, Steven Joseph

Agent Spruson & Ferguson

Pub. Number AU-B-2004238515

PCT Pub. Number WO2004/101569

Priority 60/470,780 15.05.03 US; 60/562,763 16.04.04 US

Filing date 10 May 2004

Wipo publication date 25 November 2004

Acceptance publication date 24 January 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

17 November 2005 PCT application entered the National Phase

  PCT publication WO2004/101569 Priority application(s): WO2004/101569

24 January 2008 Application Accepted

  Published as AU-B-2004238515

22 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238517-Method for coating substrates with a carbon-based material

2004238514-Method for producing a cast metal strip and corresponding twin roll casting installation